Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling

Life Sciences

Volumn 77, Issue 4, 2005, Pages 470-479

  Yono, Makoto ^a   Foster Jr , Harris E ^a   Shin, David ^a   Mane, Shrikant ^a   Latifpour, Jamshid ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 Adrenoceptors; Doxazosin; Microarray; Prostate

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CLUSTERIN; COMPLEMENTARY RNA; DOXAZOSIN; EPIREGULIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CHRONIC DRUG ADMINISTRATION; CLASSIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFICACY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HYBRIDIZATION; INSTRUMENTATION; MALE; NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BODY WEIGHT; CLUSTER ANALYSIS; DOXAZOSIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; INJECTIONS, SUBCUTANEOUS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 19344363324     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.01.004     Document Type: Article

References (28)

1. K.E. Andersson, C.R. Chapple, and K. Hofner Future drugs for the treatment of benign prostatic hyperplasia World Journal of Urology 19 6 2002 436 442
2. O.M. Bautista, J.W. Kusek, L.M. Nyberg, J.D. McConnell, R.P. Bain, G. Miller, E.D. Crawford, S.A. Kaplan, S.A. Sihelnik, M.K. Brawer, and H. Lepor Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial Controlled Clinical Trials 24 2 2003 224 243
3. J. Bendix Holme, M.M. Christensen, P.C. Rasmussen, F. Jacobsen, J. Nielsen, J.P. Nørgaard, S. Olesen, I. Noer, H. Wolf, and S. Elkjær Husted 29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study Scandinavian Journal of Urology and Nephrology 28 1 1994 77 82
4. S. Bettuzzi, R.A. Hiipakka, P. Gilna, and S. Liao Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis Biochemical Journal 257 1 1989 293 296
5. W.E. Bunney, B.G. Bunney, M.P. Vawter, H. Tomita, J. Li, S.J. Evans, P.V. Choudary, R.M. Myers, E.G. Jones, S.J. Watson, and H. Akil Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders American Journal of Psychiatry 160 4 2003 657 666
6. L.P. Deiss, E. Feinstein, H. Berissi, O. Cohen, and A. Kimchi Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death Genes and Development 9 1 1995 15 30
7. J.J. de la Rosette, B.B. Kortmann, C. Rossi, G.S. Sonke, D.L. Floratos, and L.A. Kiemeney Long-term risk of re-treatment of patients using α-blockers for lower urinary tract symptoms Journal of Urology 167 4 2002 1734 1739
8. C.J. Dunn, A. Matheson, and D.M. Faulds Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms Drugs and Aging 19 2 2002 135 161
9. S.J. Evans, N.A. Datson, M. Kabbaj, R.C. Thompson, E. Vreugdenhil, E.R. De Kloet, S.J. Watson, and H. Akil Evaluation of affymetrix gene chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial analysis of gene expression European Journal of Neuroscience 16 3 2002 409 413
10. A. Fawzy, A. Hendry, E. Cook, and F. Gonzalez Long-term (4 year) efficacy and tolerability of doxazosin for the treatment of concurrent benign prostatic hyperplasia and hypertension International Journal of Urology 6 7 1999 346 354
11. 1-adrenoceptors in the rat prostate Journal of Urology 172 6, Part 1 of 2 2004 2465 2470
12. Z.G. Goldsmith, and N. Dhanasekaran The microrevolution: applications and impacts of microarray technology on molecular biology and medicine (review) International Journal of Molecular Medicine 13 4 2004 483 495
13. D.C. Henshall, T. Araki, C.K. Schindler, S. Shinoda, J.Q. Lan, and R.P. Simon Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures Journal of Neurochemistry 86 5 2003 1260 1270
14. R. Jaatinen, M.P. Laitinen, K. Vuojolainen, J. Aaltonen, H. Louhio, K. Heikinheimo, E. Lehtonen, and O. Ritvos Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B Molecular and Cellular Endocrinology 156 1-2 1999 189 193
15. C.W. Jang, C.H. Chen, C.C. Chen, J.Y. Chen, Y.H. Su, and R.H. Chen TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase Nature Cell Biology 4 1 2002 51 58
16. R.S. Kirby, and J.L. Pool Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future British Journal of Urology 80 4 1997 521 532
17. B.H. Koo, and D.S. Kim Factor Xa induces mitogenesis of vascular smooth muscle cells via autocrine production of epiregulin Journal of Biological Chemistry 278 52 2003 52578 52586
18. N. Kyprianou Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance Journal of Urology 169 4 2003 1520 1525
19. C. Lee, L. Janulis, K. Ilio, A. Shah, I. Park, S. Kim, V. Cryns, M. Pins, and R. Bergan In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator Prostate Supplement 9 2000 21 24
20. D.K. Liu, B. Yao, B. Fayz, D.D. Womble, and S.A. Krawetz Comparative evaluation of microarray analysis software Molecular Biotechnology 26 3 2004 225 232
21. J.D. McConnell, C.G. Roehrborn, O.M. Bautista, G.L. Andriole Jr., C.M. Dixon, J.W. Kusek, H. Lepor, K.T. McVary, L.M. Nyberg Jr., H.S. Clarke, E.D. Crawford, A. Diokno, J.P. Foley, H.E. Foster, S.C. Jacobs, S.A. Kaplan, K.J. Kreder, M.M. Lieber, M.S. Lucia, G.J. Miller, M. Menon, D.F. Milam, J.W. Ramsdell, N.S. Schenkman, K.M. Slawin, and J.A. Smith The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia New England Journal of Medicine 349 25 2003 2387 2398
22. J.V. Partin, I.E. Anglin, and N. Kyprianou Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction British Journal of Cancer 88 10 2003 1615 1621
23. B. Peng, N.A. Morrice, L.C. Groenen, and R.E. Wettenhall Phosphorylation events associated with different states of activation of a hepatic cardiolipin/protease-activated protein kinase. Structural identity to the protein kinase N-type protein kinases Journal of Biological Chemistry 271 50 1996 32233 32240
24. J.A. Sensibar, D.M. Sutkowski, A. Raffo, R. Buttyan, M.D. Griswold, S.R. Sylvester, J.M. Kozlowski, and C. Lee Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin) Cancer Research 55 11 1995 2431 2437
25. V. Simon, M.T. Robin, C. Legrand, and J. Cohen-Tannoudji Endogenous G protein-coupled receptor kinase 6 triggers homologous β-adrenergic receptor desensitization in primary uterine smooth muscle cells Endocrinology 144 7 2003 3058 3066
26. N. Tørring, P.E. Jørgensen, B.S. Sørensen, and E. Nexø Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGFα and epiregulin in androgen-independent prostate cancer cell lines Anticancer Research 20 1A 2000 91 95
27. M. Yono, W. Takahashi, M. Pouresmail, D.R. Johnson, H.E. Foster Jr., R.M. Weiss, and J. Latifpour Quantification of endothelins, their receptors and endothelin-converting enzyme mRNAs in rat genitourinary tract using real-time RT-PCR Journal of Pharmacological and Toxicological Methods 48 2 2002 87 95
28. 1-adrenoceptor subtypes in the rat kidney, heart and aorta Life Sciences 75 21 2004 2605 2614